The MYST3/CREBBP rearrangement results in a cytomorphologically unique AML characterized by monocytic or myelomonocytic morphology, extramedullary involvement, DIC, and hemophagocytosis [1, 2, 5]. Here, KAT6A is linked to Hemophagocytosis.